SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001609351-19-000057
Filing Date
2019-06-03
Accepted
2019-06-03 16:17:49
Documents
1
Period of Report
2019-05-30

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_155959305330570.html 4  
1 FORM 4 wf-form4_155959305330570.xml 4 5637
  Complete submission text file 0001609351-19-000057.txt   7047
Mailing Address C/O VIROPHARMA INC 405 EAGLEVIEW BLVD EXTON PA 19341
Business Address
MILANO VINCENT (Reporting) CIK: 0001187159 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36819 | Film No.: 19873497

Mailing Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104
Business Address 3737 MARKET STREET SUITE 1300 PHILADELPHIA PA 19104 888-772-7560
Spark Therapeutics, Inc. (Issuer) CIK: 0001609351 (see all company filings)

IRS No.: 462654405 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)